Terug
Dagbereik
€ 27,46
€ 28,65
52-Weeksbereik
€ 22,24
€ 46,00
Volume
750.001
50D / 200D Gem.
€ 28,20
/
€ 33,93
Vorige Slotkoers
€ 28,11
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,0 | 0,3 |
| P/B | 1,4 | 2,9 |
| ROE % | -30,2 | 3,7 |
| Net Margin % | -764,0 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 41,50
+46.4%
Low: € 25,00
High: € 62,00
Forward WPA
-€ 6,63
Omzet Sch.
91 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,06
-€ 0,09 – -€ 0,04
|
670 M | 6 |
| FY2029 |
-€ 2,35
-€ 3,33 – -€ 1,35
|
500 M | 6 |
| FY2028 |
-€ 3,42
-€ 5,01 – -€ 1,10
|
370 M | 8 |
Belangrijkste Punten
Earnings declined -161,27% over the past year
Debt/Equity of 0,05 — conservative balance sheet
Negative free cash flow of -377,29M
PEG of 0,02 suggests growth is underpriced
Capital efficient — spends only 7,99% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)48,03%
Earnings (1Y)-161,27%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-30,20%
ROIC-28,21%
Net Margin-764,01%
Op. Margin-873,87%
Veiligheid
Debt / Equity
0,05
Current Ratio11,46
Interest Coverage0,00
Waardering
P/E Ratio
-4,02
P/B Ratio1,39
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 48,03% | Revenue Growth (3Y) | 41,92% |
| Earnings Growth (1Y) | -161,27% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 54,03M | Net Income (TTM) | -412,78M |
| ROE | -30,20% | ROA | -31,82% |
| Gross Margin | 88,26% | Operating Margin | -873,87% |
| Net Margin | -764,01% | Free Cash Flow (TTM) | -377,29M |
| ROIC | -28,21% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 11,46 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,02 | P/B Ratio | 1,39 |
| P/S Ratio | 30,74 | PEG Ratio | 0,02 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,66B | Enterprise Value | 1,63B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 54,03M | 36,50M | 26,82M | 14,24M | 0,0 |
| Net Income | -412,78M | 673,73M | -352,09M | -231,80M | 1,60B |
| EPS (Diluted) | -7,12 | 11,64 | -6,33 | -4,23 | -6,36 |
| Gross Profit | 47,68M | 32,33M | 17,32M | 12,54M | -18,78M |
| Operating Income | -472,13M | -425,74M | -391,49M | -389,05M | -378,42M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,30B | 1,66B | 937,12M | 1,24B | 1,44B |
| Total Liabilities | 104,11M | 122,24M | 126,10M | 137,90M | 145,76M |
| Shareholders' Equity | 1,19B | 1,54B | 811,02M | 1,10B | 1,29B |
| Total Debt | 62,02M | 56,99M | 72,00M | 85,66M | 97,09M |
| Cash & Equivalents | 89,13M | 76,25M | 88,21M | 139,26M | 203,13M |
| Current Assets | 942,05M | 965,60M | 833,84M | 832,77M | 1,06B |
| Current Liabilities | 82,21M | 81,16M | 67,96M | 62,63M | 59,83M |